Jolly Healthcare launches KETOJOL 4:1

Jolly Healthcare has launched KETOJOL 4:1, a ketogenic diet formulation with a 4:1 fat-to-(protein + carbohydrate) ratio, for use in clinical nutrition and paediatric neurology. The formulation is manufactured under a pharmaceutical manufacturing licence. Drug-Resistant Epilepsy (DRE) affects nearly one in three epilepsy patients, who continue to experience uncontrolled seizures despite treatment with multiple Anti-Epileptic […]